In addition, tranilast has been shown to attenuate tumour growth, angiogenesis, migration, invasion, and metastasis through down-regulation of the TGF-β signalling pathway in breast, pancreatic, gastric, and prostate cancer as well as glioma cell lines46. This evidence concerns the gene TGFB1 and Familial prostate cancer.